Expression of KDR has also been demonstrated in tumors of epithelial origin and the best rules in this study imply that the expression level of KDR is consistently lower in relation to ICAM1 and MAP2K6 when there is nodal involvement in bladder cancer. This evidence concerns the gene MAP2K6 and urinary bladder cancer.